X-FAB Silicon Foundries (XFAB) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
3 Nov, 2025Executive summary
Q3 2025 revenue reached $229 million, up 11% year-on-year and 6% quarter-on-quarter, exceeding guidance.
EBITDA was $53.9 million, up 7% YoY and 4% QoQ, with a margin of 23.6% (24.2% excluding IFRS 15).
Core markets (automotive, industrial, medical) contributed $216 million, 94% of total revenue.
CEO transition announced: Damien Macq to succeed Rudi De Winter in February 2026.
Net profit for Q3 was $16.6 million, with EPS at $0.13.
Financial highlights
Gross profit for Q3 was $48.3 million, with a margin of 21.1%, down from 24.8% YoY.
Cash and cash equivalents at quarter-end were $174.2 million, up $16.5 million from Q2; net debt decreased by $21.1 million.
CapEx for Q3 was $23.5 million; YTD CapEx: $179 million.
Net financial result was -$5.6 million, mainly due to interest expenses.
Net cash from operating activities in Q3 was $49.9 million.
Outlook and guidance
Q4 2025 revenue expected between $215 million and $225 million; EBITDA margin guidance 22.5%-25.5%.
Full-year 2025 revenue expected in the range of $863 million-$873 million.
Guidance based on USD/EUR rate of 1.17, excluding IFRS 15 impact.
Visibility remains limited due to macroeconomic and geopolitical uncertainties.
Latest events from X-FAB Silicon Foundries
- Q4 revenue up 18% YoY to $222.3M; industrial and medical growth offset automotive softness.XFAB
Q4 20259 Feb 2026 - Q2 revenue fell 9% year-on-year to $205.1M; SiC weakness led to lower guidance, but Q4 rebound expected.XFAB
Q2 20242 Feb 2026 - Q3 revenue up sequentially, China automotive strong, CapEx high, full-year guidance lowered.XFAB
Q3 202418 Jan 2026 - Double-digit growth, major expansions, and $1.5B revenue and 35% margin targeted by 2030.XFAB
Investor Day 202411 Jan 2026 - Three-pillar strategy and $1.1B expansion drive growth in specialty semiconductors.XFAB
CMD 202531 Dec 2025 - Q1 revenue up 8% sequentially, EBITDA margin 24%, guidance and expansion plans reaffirmed.XFAB
Q1 202523 Dec 2025 - 2024 saw revenue and profit declines amid destocking, but recovery and margin gains are expected.XFAB
Q4 202423 Dec 2025 - Q2 revenue up to 8% year-over-year, guidance raised, and capacity expansion completed.XFAB
Q2 202516 Nov 2025